Hyun Lee1, Suk Hyeon Jeong1, Byeong-Ho Jeong1, Hye Yun Park1, Kyung-Jong Lee1, Sang-Won Um1, O Jung Kwon1, Hojoong Kim2. 1. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. 2. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address: hjk3425@skku.edu.
Abstract
INTRODUCTION: Current National Comprehensive Cancer Network guidelines recommend routine brain magnetic resonance imaging (MRI) screening in patients with stage II to IV non-small cell carcinoma, regardless of histological subtype. This recommendation might not be universally applicable, however, because brain metastasis (BM) is seen less frequently in patients with lung squamous cell carcinoma (SCC) than in those with a histological diagnosis of nonsquamous cell carcinoma. METHODS: The cases of 564 patients with lung SCC in our institution between January 2012 and December 2013 were reviewed prospectively for comprehensive staging. All subjects' lung SCC, but not their BM, was staged on the basis of the seventh edition of the guidelines of the American Joint Committee on Cancer. We evaluated the incidence of BM across the stages and clinical factors associated with BM. RESULTS: Of the 564 patients, 28 (5.0%) had BM. BM did not occur in patients with stage Ia or Ib disease; however, it increased significantly as the disease progressed from stage IIa to IV (p < 0.001, trend test). Multivariate analysis showed that tumor involvement in N3 lymph nodes and distant metastasis other than BM (M1b) was independently associated with the development of BM. CONCLUSIONS: Routine brain MRI screening in patients with lung SCC in stage II to IV can help to evaluate asymptomatic BM. By contrast, we did not find any evidence supporting routine brain MRI screening in patients with stage I disease.
INTRODUCTION: Current National Comprehensive Cancer Network guidelines recommend routine brain magnetic resonance imaging (MRI) screening in patients with stage II to IV non-small cell carcinoma, regardless of histological subtype. This recommendation might not be universally applicable, however, because brain metastasis (BM) is seen less frequently in patients with lung squamous cell carcinoma (SCC) than in those with a histological diagnosis of nonsquamous cell carcinoma. METHODS: The cases of 564 patients with lung SCC in our institution between January 2012 and December 2013 were reviewed prospectively for comprehensive staging. All subjects' lung SCC, but not their BM, was staged on the basis of the seventh edition of the guidelines of the American Joint Committee on Cancer. We evaluated the incidence of BM across the stages and clinical factors associated with BM. RESULTS: Of the 564 patients, 28 (5.0%) had BM. BM did not occur in patients with stage Ia or Ib disease; however, it increased significantly as the disease progressed from stage IIa to IV (p < 0.001, trend test). Multivariate analysis showed that tumor involvement in N3 lymph nodes and distant metastasis other than BM (M1b) was independently associated with the development of BM. CONCLUSIONS: Routine brain MRI screening in patients with lung SCC in stage II to IV can help to evaluate asymptomatic BM. By contrast, we did not find any evidence supporting routine brain MRI screening in patients with stage I disease.
Authors: Hyun Woo Lee; Jaeyoung Cho; Nakwon Kwak; Inpyeong Hwang; Young Sik Park; Chang-Hoon Lee; Sang-Min Lee; Chul-Gyu Yoo; Young Whan Kim; Sun Mi Choi Journal: ERJ Open Res Date: 2020-09-14
Authors: Sung Jun Ahn; Hyeokjin Kwon; Jun Won Kim; Goeun Park; Mina Park; Bio Joo; Sang Hyun Suh; Yoon Soo Chang; Jong-Min Lee Journal: Front Oncol Date: 2022-05-10 Impact factor: 5.738
Authors: Garrett T Wasp; Christopher Del Prete; Jonathan A D Farrell; Konstantin H Dragnev; Gregory Russo; Graham T Atkins; Joseph D Phillips; Gabriel A Brooks Journal: Heliyon Date: 2020-06-29
Authors: Sebastian Johannes Müller; Eya Khadhraoui; Nicole E Neef; Christian Heiner Riedel; Marielle Ernst Journal: BMC Med Imaging Date: 2021-04-15 Impact factor: 1.930